GIP
AERI

Granite Investment Partners’s Aerie Pharmaceuticals AERI Stock Holding History

Granite Investment Partners’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-468,152
Closed -$3.51M – 280
2022
Q2 		$3.51M Sell
468,152
-70,000
-13% -$493K 0.15% 166
2022
Q1 		$4.9M Buy
538,152
+60,702
+13% +$468K 0.17% 148
2021
Q4 		$3.35M Buy
477,450
+66,684
+16% +$698K 0.1% 184
2021
Q3 		$4.68M Buy
410,766
+110,675
+37% +$1.62M 0.15% 139
2021
Q2 		$4.8M Sell
300,091
-38,894
-11% -$667K 0.15% 138
2021
Q1 		$6.06M Sell
338,985
-134,913
-28% -$2.33M 0.2% 122
2020
Q4 		$6.4M Buy
473,898
+54,647
+13% +$660K 0.22% 113
2020
Q3 		$4.93M Buy
419,251
+173,418
+71% +$2.11M 0.22% 118
2020
Q2 		$3.63M Buy
245,833
+146,667
+148% +$2.17M 0.17% 129
2020
Q1 		$1.34M Buy
99,166
+49,529
+100% +$940K 0.09% 196
2019
Q4 		$1.2M Buy
+49,637
New +$1.03M 0.06% 220
2019
Q2 		– Sell
-280,778
Closed -$13.3M – 376
2019
Q1 		$13.3M Buy
+280,778
New +$12.4M 0.76% 58

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Granite Investment Partners's AERI Position: Q3 2022 in Review

Granite Investment Partners sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 468,152 shares — an estimated $3.51M sold.

Granite Investment Partners first reported a position in AERI in Q1 2019 and held it in 12 quarters. The position peaked at $13.3M in Q1 2019. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • Granite Investment Partners reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Granite Investment Partners sold 468,152 Aerie Pharmaceuticals shares in Q3 2022, an estimated $3.51M.
  • Granite Investment Partners first reported a position in Aerie Pharmaceuticals in Q1 2019 and held it in 12 quarters.
  • Granite Investment Partners's Aerie Pharmaceuticals position peaked at $13.3M in Q1 2019.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Granite Investment Partners's 13F filing for Q3 2022, filed 24 Oct 2022.